Mind Medicine (MindMed) I... (MNMD)
Mind Medicine (MindMed) Statistics
Share Statistics
Mind Medicine (MindMed) has 75.37M shares outstanding. The number of shares has increased by 6.9% in one year.
| Shares Outstanding | 75.37M |
| Shares Change (YoY) | 6.9% |
| Shares Change (QoQ) | 2.78% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 72.71M |
| Failed to Deliver (FTD) Shares | 40.77K |
| FTD / Avg. Volume | 2.04% |
Short Selling Information
The latest short interest is 10.43M, so 14.23% of the outstanding shares have been sold short.
| Short Interest | 10.43M |
| Short % of Shares Out | 14.23% |
| Short % of Float | 14.71% |
| Short Ratio (days to cover) | 7.73 |
Valuation Ratios
The PE ratio is -4.51 and the forward PE ratio is -4.85. Mind Medicine (MindMed)'s PEG ratio is 0.12.
| PE Ratio | -4.51 |
| Forward PE | -4.85 |
| PS Ratio | 0 |
| Forward PS | 0.7 |
| PB Ratio | 2.03 |
| P/FCF Ratio | -6.2 |
| PEG Ratio | 0.12 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Mind Medicine (MindMed).
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.25, with a Debt / Equity ratio of 0.09.
| Current Ratio | 7.25 |
| Quick Ratio | 7.25 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.21 |
| Debt / FCF | -0.28 |
| Interest Coverage | 45.52 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.47M |
| Employee Count | 74 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -48.61% in the last 52 weeks. The beta is 2.39, so Mind Medicine (MindMed)'s price volatility has been higher than the market average.
| Beta | 2.39 |
| 52-Week Price Change | -48.61% |
| 50-Day Moving Average | 7.1 |
| 200-Day Moving Average | 6.99 |
| Relative Strength Index (RSI) | 35.82 |
| Average Volume (20 Days) | 2M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -103.92M |
| Net Income | -108.68M |
| EBITDA | -103.92M |
| EBIT | -110.96M |
| Earnings Per Share (EPS) | -1.54 |
Balance Sheet
The company has 273.74M in cash and 21.85M in debt, giving a net cash position of 251.89M.
| Cash & Cash Equivalents | 273.74M |
| Total Debt | 21.85M |
| Net Cash | 251.89M |
| Retained Earnings | -398.88M |
| Total Assets | 302.15M |
| Working Capital | 242.77M |
Cash Flow
In the last 12 months, operating cash flow was -79.13M and capital expenditures 0, giving a free cash flow of -79.13M.
| Operating Cash Flow | -79.13M |
| Capital Expenditures | 0 |
| Free Cash Flow | -79.13M |
| FCF Per Share | -1.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MNMD is $20, which is 260.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $20 |
| Price Target Difference | 260.4% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Stock Splits
The last stock split was on Aug 29, 2022. It was a backward split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | 1.97 |
| Piotroski F-Score | 2 |